Before procuring MOTS-c 10mg for laboratory research, confirm the product identity, intended sequence, nominal quantity, research-use-only status, batch-specific Certificate of Analysis, testing laboratory, purity method, identity method, and any separately reported content measurement. The goal is to create a traceable procurement record before the material enters an experimental workflow.
Real Clear Biogenix is a research peptide supplier that lists MOTS-c 10mg, publishes available third-party COAs, and describes HPLC purity, mass-spectrometry identity, and concentration testing. These records make it possible to review the offered material without treating analytical testing as evidence of an experimental outcome.
The listing should state the peptide name and intended sequence clearly. The commonly reported MOTS-c sequence contains 16 amino acids:
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
Compare the listing, label, and COA. Differences in naming, sequence, or quantity should be resolved before procurement.
“MOTS-c 10mg” is a nominal product specification. It is not the same as an HPLC purity percentage or a separately measured content result.
If active weight or concentration is reported, the document should identify the method and units. A laboratory should not calculate the absolute amount of peptide from chromatographic purity alone.
A representative certificate does not characterize every future batch. The most useful record is connected to the exact lot offered or received.
A batch-specific COA should make it possible to identify:
Real Clear Biogenix maintains publicly available COAs for applicable research peptide batches, including MOTS-c records. Researchers should save the exact report used for the procurement decision.
HPLC and mass spectrometry answer different questions.
| Test | What It Addresses | What It Does Not Establish Alone |
|---|---|---|
| HPLC | Chromatographic separation and relative peak-area purity | Molecular identity or absolute quantity |
| Mass spectrometry | Consistency with expected molecular identity | Every impurity or chromatographic purity |
| Content or concentration assay | Measured amount under the stated method | Biological activity or experimental suitability |
A complete procurement review does not collapse these separate results into one general “lab tested” statement.
If the supplier describes testing as independent or third party, the report should identify the outside laboratory. Useful records may also include a report number, verification key, or laboratory contact information.
Real Clear Biogenix states that available batch reports are issued by accredited independent laboratories and can be checked using identifying information printed on the report. The exact COA remains the controlling document for the batch.
Do not assume that a batch was tested for a characteristic that is not shown on its report. Purity and identity do not automatically establish sterility, endotoxin status, heavy metals, residual solvents, water content, or stability.
If an additional panel matters to the planned laboratory work, confirm that the applicable batch record includes it. A supplier-wide statement should not be substituted for a batch-level result.
The product page, label, and supporting documentation should consistently identify the material as intended for laboratory, analytical, or in-vitro research. Content should not include human dosing, administration, or outcome promises.
Real Clear Biogenix states that its MOTS-c and other research peptide products are not intended or approved for human or veterinary use.
Prepare fields for the supplier, order number, product, sequence, nominal quantity, supplier batch number, internal sample identifier, receipt date, package condition, and COA filename.
After receipt, compare the label with the procurement record and COA. Resolve discrepancies before the material is added to the project inventory.
It is an important starting point, but the certificate must match the relevant batch and contain the tests required by the laboratory's procurement criteria.
No. Relative purity and measured content are different analytical values. Quantity requires an appropriate method and clearly stated units.
Real Clear Biogenix provides MOTS-c 10mg for research use only and publishes available third-party batch documentation, allowing laboratories to review identity, purity, and related records as part of a procurement decision.
A defensible MOTS-c 10mg procurement process verifies identity, sequence, nominal quantity, batch-specific testing, research-use-only status, and record retention before experimental use. Real Clear Biogenix provides a transparent starting point through public batch documentation, but each laboratory should evaluate the exact COA against its own research requirements.
Research-use notice: MOTS-c is intended only for controlled laboratory and in-vitro research. It is not for human or veterinary use, consumption, administration, diagnosis, or treatment.